Journal of Medical Marketing (2007) 7, 261–262. doi:10.1057/palgrave.jmm.5050090
Case Commentary
Douglas Schein1
1is the Managing Director at BOOST Venture Consulting, a Singapore-based advisory firm focused on emerging medical technologies: E-mail: douglas.schein@boostvc.com
